Inference Gap in Domain Expertise and Machine Intelligence in Named Entity Recognition: Creation of and Insights from a Substance Use-related Dataset

TL;DR

This paper introduces a new dataset and NER framework for extracting opioid-related impacts from social media, highlighting the importance of domain-specific fine-tuning and revealing a significant gap between AI and expert performance.

Contribution

The study presents RedditImpacts 2.0, a high-quality dataset with refined annotations, and demonstrates the effectiveness of fine-tuned models over LLMs in domain-specific NER tasks.

Findings

Fine-tuned DeBERTa-large achieves F1 of 0.61

Strong performance with less labeled data

Significant gap between AI and expert agreement

Abstract

Nonmedical opioid use is an urgent public health challenge, with far-reaching clinical and social consequences that are often underreported in traditional healthcare settings. Social media platforms, where individuals candidly share first-person experiences, offer a valuable yet underutilized source of insight into these impacts. In this study, we present a named entity recognition (NER) framework to extract two categories of self-reported consequences from social media narratives related to opioid use: ClinicalImpacts (e.g., withdrawal, depression) and SocialImpacts (e.g., job loss). To support this task, we introduce RedditImpacts 2.0, a high-quality dataset with refined annotation guidelines and a focus on first-person disclosures, addressing key limitations of prior work. We evaluate both fine-tuned encoder-based models and state-of-the-art large language models (LLMs) under zero- and few-shot in-context learning settings. Our fine-tuned DeBERTa-large model achieves a relaxed token-level F1 of 0.61 [95% CI: 0.43-0.62], consistently outperforming LLMs in precision, span accuracy, and adherence to task-specific guidelines. Furthermore, we show that strong NER performance can be achieved with substantially less labeled data, emphasizing the feasibility of deploying robust models in resource-limited settings. Our findings underscore the value of domain-specific fine-tuning for clinical NLP tasks and contribute to the responsible development of AI tools that may enhance addiction surveillance, improve interpretability, and support real-world healthcare decision-making. The best performing model, however, still significantly underperforms compared to inter-expert agreement (Cohen's kappa: 0.81), demonstrating that a gap persists between expert intelligence and current state-of-the-art NER/AI capabilities for tasks requiring deep domain knowledge.